MetaCap

CytoMed Therapeutics Insider Trades

NASDAQ: GDTCHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.755-0.018 (-2.33%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
5 · $728.78K
Sales
0 · $0
Shares bought / sold
512.00K / 0
Net activity
Net buying $728,778

CytoMed Therapeutics insider activity

Over the last 12 months, CytoMed Therapeutics insiders reported 5 transactions on SEC Form 4: 5 open-market purchases and 0 sales. Insiders bought $728,778 and sold $0 worth of stock, for net insider buying of $728,778. The most recent filing shows Choo Chee Kong (Director) buying 100,000 shares at $1.50 on Jul 20, 2026.

Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put GDTC's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

GDTC insider transactions

CytoMed Therapeutics insider transactions
DateInsiderTypeSharesValueFiling
Jul 20, 2026Choo Chee KongDirectorBuy100,000$150.00KForm 4
Jul 20, 2026Choo Chee KongDirectorBuy100,000$150.00KForm 4
Jul 14, 2026Choo Chee KongDirectorBuy100,000$150.00KForm 4
Jul 14, 2026Choo Chee KongDirectorBuy100,000$150.00KForm 4
May 13, 2026Choo Chee KongDirectorBuy112,000$128.78KForm 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related